Is Private Cord Blood Banking a Medical Breakthrough or a Multithousand-Dollar Marketing Trap?

In today's episode we're uncovering the multi-billion-dollar marketing behind private umbilical cord tissue banking.

Expectant parents are often sold a dream: pay hefty storage fees now to safeguard their child's future health against major medical conditions.

But how much of that aggressive sales pitch aligns with FDA regulations and actual clinical realities?

We compare bold industry claims against the strict FDA limitations governing stem cell therapies, examine the extremely rare list of approved indications, and reveal why banking cord blood for common diseases might never pay off.

Before signing expensive storage contracts, discover what parents really need to know about regenerative wellness.

=== REFERENCES ===

• https://regenexx.com/blog/the-save-the-cord-ripoff-the-insurance-policy-for-very-very-very-rare-diseases/
• https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/utah-cord-bank-llc-dba-utah-cell-bank-614013-08102021

Become a supporter of this podcast: https://www.spreaker.com/podcast/foodnourish-deep-dives--6602003/support.

🤗 Support the show: Become a supporter for just 2€ per month to remove advertisements and help us continue bringing interesting topics while confronting mainstream narratives on health.

Support FoodNourish Deep Dives

This episode includes AI-generated content.